Abstract
Taurine, a colourless water soluble, two carbon atom ß amino ethane sulphonic acid (NH2-CH2CH2SO3H, CA registry No 107-35-7) was first isolated from Ox Gile in 1827. It is derived from methionine and cysteine catabolism. The mammalian cell metabolism does not use taurine either as a source of energy or as a source of inorganic sulfate or organic sulfur. This amino acid is also not part of any protein but remains free in intercellular water. It is abundant in electrically excited tissues such as skeletal and cardic, nervous and platelets. In brain its concentration is exceeded only by glutamic acid. Besides its well known functions in bile salt amidation, taurine is involved in a broad spectrum of metabolic processes including modulation of calcium flux, modulation of neuronal excitability, detoxification, anti-oxidation, membrane stabilization and antiepilepsy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gupta, R.C. (2000). New Taurine Analogues in Treatment Strategies for Parkinson’s Disease. In: Storch, A., Collins, M.A. (eds) Neurotoxic Factors in Parkinson’s Disease and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1269-1_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1269-1_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5470-3
Online ISBN: 978-1-4615-1269-1
eBook Packages: Springer Book Archive